Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ENTX is expected to report earnings to rise 16.67% to -7 cents per share on May 09

Q1'25

Est.

$-0.07

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.03

Q2'24

Est.

$-0.06

Q1'24

Beat

by $0.07

The last earnings report on March 28 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 158.02K shares outstanding, the current market capitalization sits at 109.01M.

View a ticker or compare two or three

Compare

ENTX